Endocrinology, Vol 133, 199-207, Copyright © 1993 by Endocrine Society

ARTICLES

Menstrual stage-specific expression of epidermal growth factor and transforming growth factor-alpha in human oviduct epithelium and their role in early embryogenesis

K Morishige, H Kurachi, K Amemiya, H Adachi, K Adachi, Y Sakoyama, A Miyake and O Tanizawa
Department of Obstetrics and Gynecology, Osaka University Medical School, Japan.

We studied the expression of epidermal growth factor (EGF) and transforming growth factor (TGF)-alpha in human oviduct epithelium at various menstrual stages. Immunohistochemical stainings using anti-EGF and anti-TGF alpha antibodies showed a specific staining in ampullary oviduct epithelium at late follicular and luteal stages, but the stainings were very weak at early follicular stage. Quantitative reverse transcription and polymerase chain reaction, using beta-actin messenger RNA as an internal standard, revealed the menstrual stage- specific expression of EGF and TGF alpha gene transcripts: relative amounts of EGF and TGF alpha messenger RNA to those of beta-actin were 1.5 +/- 1.9% (mean +/- SD) and 1.4 +/- 0.6% (n = 3) at early follicular, 16.5 +/- 4.9% and 12.6 +/- 2.6% (n = 3) at late follicular, and 18.9 +/- 2.2% and 13.8 +/- 3.2% (n = 3) at luteal stages, respectively. The expression of these growth factors was in proportion to the increase in serum estradiol but not to progesterone levels. To clarify the biological significance of these growth factors, mouse two- cell embryos were cocultured with human oviduct epithelial cells with or without blocking the action of these growth factors. Cocultures significantly promoted blastocyst formation, but this promotive effect of the oviduct epithelial cells was completely abolished by the addition of anti-EGF and/or anti-TGF alpha monoclonal neutralizing antibodies to the coculture system. All these results showed that EGF and TGF alpha were synthesized and expressed in human oviduct epithelium specifically to menstrual stages, and that these growth factors may be involved in early embryonic development.

This article has been cited by other articles:

				S. Mishra, Z.M. Lei, and Ch.V. Rao A Novel Role of Luteinizing Hormone in the Embryo Development in Cocultures Biol Reprod, April 1, 2003; 68(4): 1455 - 1462. [Abstract] [Full Text] [PDF]

				C. Grondahl, J. Breinholt, P. Wahl, A. Murray, T. H. Hansen, I. Faerge, C. E. Stidsen, K. Raun, and C. Hegele-Hartung Physiology of meiosis-activating sterol: endogenous formation and mode of action Hum. Reprod., January 1, 2003; 18(1): 122 - 129. [Abstract] [Full Text] [PDF]

				B. Moller, C. Rasmussen, B. Lindblom, and M. Olovsson Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle Mol. Hum. Reprod., January 1, 2001; 7(1): 65 - 72. [Abstract] [Full Text] [PDF]

				E. R. Hernandez Embryo implantation and GnRH antagonists: Embryo implantation: the Rubicon for GnRH antagonists Hum. Reprod., June 1, 2000; 15(6): 1211 - 1216. [Abstract] [Full Text] [PDF]

				N. Desai, J. Lawson, and J. Goldfarb Assessment of growth factor effects on post-thaw development of cryopreserved mouse morulae to the blastocyst stage Hum. Reprod., February 1, 2000; 15(2): 410 - 418. [Abstract] [Full Text] [PDF]

				D. L. Schell, P. A. Mavrogianis, A. T. Fazleabas, and H. G. Verhage Epidermal Growth Factor, Transforming Growth Factor-{alpha}, and Epidermal Growth Factor Receptor Localization in the Baboon (Papio anubis) Oviduct During Steroid Treatment and the Menstrual Cycle Reproductive Sciences, October 1, 1994; 1(4): 269 - 276. [Abstract] [PDF]